Hepatocellular Carcinoma

New Biomarker-guided Strategy Has Potential For Liver Cancer Treatment

A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the...
Related topics: Liver Cancer, Cancer, Oncology, Medical Research

Read More →

Adverse Liver Outcomes Up With Diagnosis Of Nafld/nash

WEDNESDAY, May 22, 2019 -- The risks for cirrhosis and hepatocellular carcinoma (HCC) are increased for patients with a recorded diagnosis of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), according to a study...
Related topics: Liver Disease, Cirrhosis, Medical Research

Read More →

Exelixis Expands Its Sales

Exelixis' (NASDAQ: EXEL) Cabometyx continues to take market share as the biotech captures more kidney cancer (renal cell carcinoma) patients and launches into liver cancer (hepatocellular carcinoma) following the Food and Drug Administration...
Related topics: Nasdaq, Kidney Cancer, Cancer, Liver Cancer, Oncology, Food And Drug Administration

Read More →

Higher Intake Of Whole Grains May Lower Risk For Liver Cancer

MONDAY, March 4, 2019 -- Higher intake of whole grains may be associated with a lower risk for hepatocellular carcinoma (HCC) among U.S. adults, according to a study published online Feb. 21 in JAMA Oncology. Wanshui Yang, Ph.D., from Anhui...
Related topics: Liver Cancer, Cancer, Oncology, Medical Research

Read More →

Direct-acting Antivirals Cut Mortality In Chronic Hepatitis C

TUESDAY, Feb. 12, 2019 -- For adults with chronic hepatitis C virus (HCV) infection, direct-acting antivirals are associated with a reduced risk for mortality and hepatocellular carcinoma, according to a study published online Feb. 11 in The...
Related topics: Hepatitis, Hepatitis C, Virus, Virology, Medical Research

Read More →

Regular Aspirin Use Curbs Risk Of Liver And Ovarian Cancer

Two new studies show that regular long-term aspirin use was linked to a lower risk of hepatocellular carcinoma and ovarian cancer Medscape Medical News
Related topics: Aspirin, Liver Cancer, Ovarian Cancer, Cancer, Oncology

Read More →

Roche's Tecentriq Gets Breakthrough Therapy Status For Hcc

Roche Holding AG RHHBY announced that the FDA has granted breakthrough therapy designation to its immuno-oncology drug, Tecentriq, in combination with Avastin for the first-line treatment of advanced hepatocellular carcinoma (HCC).The...
Related topics: Food And Drug Administration, Cancer, Oncology, Avastin

Read More →

Exelixis Slides Despite Positive Late-stage Results

Shares of Exelixis slipped on Wednesday after the company reported results from its late-stage trial of cabozantinib for advanced hepatocellular carcinoma.

Read More →

Bristol-myers (bmy) Opdivo Gets Approval For Liver Cancer

Bristol-Myers Squibb Company BMY announced that the FDA has approved immuno-oncology drug Opdivo for intravenous use for patients with hepatocellular carcinoma (HCC) who have been previously treated with  Nexavar.The approval for this...
Related topics: Bristol-Myers Squibb, Liver Cancer, Cancer, Oncology, Food And Drug Administration

Read More →

Liver Tumor Growth In Mice Slowed With New Chemo-immunotherapy Treatment

Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine researchers have...
Related topics: Liver Cancer, Liver Disease, Cancer, Chemotherapy, Oncology, Medical Research

Read More →

Nccn Awards 3 Grants To Investigators To Study Bavituximab In Combination With Other Therapeutic...

The NCCN Oncology Research Program has awarded research grants to three investigators to study bavituximab in glioblastoma, head and neck cancer, and hepatocellular carcinoma.
Related topics: Medical Research, Cancer, Oncology, Glioblastoma

Read More →

New Hepatocellular Carcinoma Prognostic Model Improves Prediction Of Patient Survival

The ITA.LI.CA prognostic system, a model integrating tumor staging, liver function, functional status, and alpha-fetoprotein level, builds on previous models of hepatocellular carcinoma (HCC) prognosis and shows superior survival prediction in...
Related topics: Cancer, Liver Cancer

Read More →

Towards The Goal Of Precision Therapy In Hepatocellular Carcinoma

Hepatocellular carcinoma is a highly lethal disease, therefore effective and tolerable treatment is urgently needed. Authors of a new report provide an updated review of the genetic abnormalities and mechanisms that drive carcinogenesis of HCC, and...
Related topics: Genetics

Read More →

Scientists Root Out The 'bad Seeds' Of Liver Cancer

The Achilles heel of hepatocellular carcinoma, a leading cause of cancer deaths worldwide, has been discovered by researchers. The key to disrupting chemo-resistant stem cells that become liver tumors from multiplying is to target the stem cell...
Related topics: Liver Cancer, Cancer, Oncology, Medical Research, Chemotherapy, Stem Cells

Read More →

Screening For Hepatocellular Carcinoma

Learn the risk factors for hepatocellular carcinoma, and who to screen, how often to screen, and what tools should be used. Medscape Gastroenterology

Read More →

Medical News Today: Outreach Invitations Boost Hcc Screening In Cirrhosis Patients

New research presented at a conference in Paris suggests outreach interventions may increase screening for hepatocellular carcinoma in patients with cirrhosis.
Related topics: Cirrhosis, Medical Research

Read More →

Variations In Liver Cancer Attributable To Hepatitis Virus Variations

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences...
Related topics: Liver Cancer, Liver Disease, Cancer, Oncology, Viral Hepatitis, Hepatitis, Hepatitis C, Hepatitis B, Virus, Virology

Read More →

Novel Therapeutic Candidate Targets Key Driver Of Hcc In Genomically Defined Subset Of Patients

Findings on a novel therapeutic candidate for a genomically defined subset of hepatocellular carcinoma (HCC) patients with an aberrant fibroblast growth factor receptor 4 (FGFR4) pathway have been presented. BLU-554, a small molecule inhibitor of...

Read More →

Coffee Linked With Lower Liver Cancer Risk

Your daily coffee habit could protect you from developing the most common kind of liver cancer, a new study suggests. And the more coffee you drink a day, the lower the risk of hepatocellular carcinoma, according to researchers from the University...
Related topics: Liver Cancer, Cancer, Medical Research, Oncology

Read More →

Bayer/amgen's Nexavar Fails In Late-stage Study - Analyst Blog

The HealthCare segment at Bayer (BAYRY) and partner, Amgen Inc. (AMGN), announced disappointing results from a phase III STORM (Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma) study on Nexavar. The...
Related topics: Amgen

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.